Basic Research Open Access
Copyright ©The Author(s) 2004. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Sep 15, 2004; 10(18): 2680-2689
Published online Sep 15, 2004. doi: 10.3748/wjg.v10.i18.2680
Gene expression differences of regenerating rat liver in a short interval successive partial hepatectomy
Cun-Shuan Xu, An-Shi Zhang, Hong-Peng Han, Jin-Yun Yuan, Cui-Fang Chang, Wen-Qiang Li, Ke-Jin Yang, Li-Feng Zhao, Yu-Chang Li, Hui-Yong Zhang, Salman Rahman, Jing-Bo Zhang
Cun-Shuan Xu, Hong-Peng Han, Jin-Yun Yuan, Cui-Fang Chang, Ke-Jin Yang, Li-Feng Zhao, College of Life Sciences, Henan Normal University, Xinxiang 453007, Henan Province, China
Salman Rahman, Homophilia Research Center, London University, London SE17EH, United Kingdom
An-Shi Zhang, Wen-Qiang Li, Yu-Chang Li, Hui-Yong Zhang, Jing-Bo Zhang, State Key Laboratory of Cell Differentiation and Regulation of Province and Ministry, Xinxiang 453007, Henan Province, China
Author contributions: All authors contributed equally to the work.
Supported by the National Natural Science Foundation of China, No. 30270673
Correspondence to: Professor Cun-Shuan Xu, College of Life Sciences, Henan Normal University, Xinxiang 453007, Henan Province, China.
Telephone: +86-373-3326001 Fax: +86-373-3326524
Received: October 29, 2003
Revised: December 1, 2003
Accepted: December 16, 2003
Published online: September 15, 2004


AIM: To identify the genes expressed differentially in the regenerating rat liver in a short interval successive partial hepatectomy (SISPH), and to analyze their expression profiles.

METHODS: Five hundred and fifty-one elements selected from subtractive cDNA libraries were conformed to a cDNA microarray (cDNA chip). An extensive gene expression analysis following 0-36-72-96-144 h SISPH was performed by microarray.

RESULTS: Two hundred and sixteen elements were identified either up- or down-regulated more than 2-fold at one or more time points of SISPH. By cluster analysis and generalization analysis, 8 kinds of ramose gene expression clusters were generated in the SISPH. Of the 216 elements, 111 were up-regulated and 105 down-regulated. Except 99 unreported genes, 117 reported genes were categorized into 22 groups based on their biological functions. Comparison of the gene expression in SISPH with that after partial hepatectomy (PH) disclosed that 56 genes were specially altered in SISPH, and 160 genes were simultaneously up-regulated or down-regulated in SISPH and after PH, but in various amount and at different time points.

CONCLUSION: Genes expressed consistently are far less than that intermittently; the genes strikingly increased are much less than that increased only 2-5 fold; the expression trends of most genes in SISPH and in PH are similar, but the expression of 56 genes is specifically altered in SISPH. Microarray combined with suppressive subtractive hybridization can in a large scale effectively identify the genes related to liver regeneration.


In the liver regeneration (LR) after partial hepatectomy (PH), a great deal of genes is involved, and varied in the different phases of LR[1-5]. Peak of DNA synthesis appears at 24 h and two small peaks occur at 36 h and 48 h after PH[6]. Despite numerous related papers, the molecular mechanism of LR has not been thoroughly elucidated[7-16]. To explore the hepatic regeneration mechanism, a 0-36-72-96-144 h short interval successive partial hepatectomy (SISPH) model was established in 2001, and has been proved an important tool for studying specific gene expression at various crucial points of LR[17-19]. To uncover unknown differential display genes relevant to LR, the method of subtractive suppression hybridization (SSH) was used, and a bulk of up-regulated and down-regulated expressed sequence tags (ESTs) in the regenerating rat liver of 0-36-72-96-144 h SISPH were obtained. With development of cDNA microarray technology, genomewide expression of thousands of genes can be simultaneously analyzed facilitating differential expression monitoring of a large number of activated or suppressed genes under various biological conditions. To further display their expression variation in the LR, an in-house cDNA microarray was successfully performed to identify gene expression profiles in regenerating liver following the SISPH. Relevant information was achieved by data analysis of Microsoft Excel and GeneSpring.

Short interval successive partial hepatectomy of rats

Male and female Sprague-Dawley (SD) rats, aged 10-12 wk and weighing 200-220 g, were raised in Experimental Animal Center of Henan Normal University. According to Xu et al[20], lobule external sinister and lobus centralis sinister, lobus dexter, lobus centralis, and lobus caudatus were removed subsequently at four time points of 0, 36, 72, 96 h of 0-36-72-96-144 h SISPH.

Sample preparation and RNA extraction

The removed liver lobes were rinsed in cold 1 × PBS and immersed in -80 °C refrigerator for RNA and protein extraction. Total RNA was isolated from frozen liver lobes according to the manual of Trizol kit of Invitrogen. In brief, 50-100 mg liver tissue was homogenized in 1 mL Trizol reagent containing phenol and guanidinium isothiocyanate/cationic detergent, followed by phenol-chloroform extraction and isopropyl alcohol precipitation. The quantity and integrity of total RNA were examined by ultraviolet spectrometer and denaturing formaldehyde agarose electrophoresis stained by ethidium bromide (EB).

Subtracted cDNA library construction and screening

cDNA subtractive libraries were generated from total RNA by PCR-Select TM cDNA Subtraction kit (Clontech) following the manufacturer’s instruction. Briefly, total RNA was reverse transcribed to double cDNA strands and digested with restriction enzymes, followed by subtractive hybridization with drivers and testers. Finally with suppression PCR, differential expression sequence tags were performed to construct subtractive cDNA library, which was cloned into T-vector (Promega) and screened by PCR with nest primer 1 and 2.

Sequence analysis

The base sequence assay of ESTs was carried out according to the current protocols in molecular biology. All sequences were determined for both strands. Comparison analysis of the selected sequences was conducted with the DNAman and the National Center for Biotechnology Information ( GenBank database.

cDNA microarray construction

cDNA fragments amplified by polymerase chain reaction (PCR) with nested PCR primer 1 and primer 2, and purified by NaAc/isopropanol were spotted onto glass slides (Biostar) with the help of ProSys-5510A spotting machine according to designed project. Then the gene chips were ready by hydrating, blocking and drying. Totally 1152 elements (double spot chip) including 50 control systems (8 negative control, 12 blank control, 30 internal control) and 551 target genes to be studied comprised 8 submatrixes (12*12) occupying 9 mm × 18 mm (Biostar).

Fluorescence-labeled cDNA preparation

RNA isolated from rat livers before SISPH served as a reference for all cDNA microarray analyses. Total denatured RNA was reverse transcribed with Cy3-conjugated dCTP (control group) and Cy5-conjugated dCTP (test group) (Amersham-Pharmacia Biotech) using MMLV reverse transcriptase (Promega) with olig (dT) primer. After bath incubation for 2 h, labeled buffer I and II were subsequently added to the reaction. The control group and test group were mingled together symmetrically and stored in the dark for use.

Hybridization and scanning

The glass slices were prehybridized at 42 °C for 5-6 h in hybridization buffer containing freshly cooked shared salmon sperm DNA. The labeled denatured probe was hybridized against cDNA microarrays with an overnight (16-18 h) incubation at 42 °C. The slides were then washed twice with 2 × SSC containing 5 g/L SDS for 5 min at room temperature, once with 0.2 × SSC containing 5 g/L SDS at 60 °C for 10 min, and finally with 0.2 × SSC at 60 °C for 10 min. After that, the slices were photographed. Hybridized images were scanned by a fluorescence laser scanning device, Gene Pix 4000 A (Axon Instruments, Inc., Foster City, CA). At least two hybridizations were performed at each time point. In addition, a semiquantitative inspection of the hybridization results was performed for (1) green signal (down regulation); (2) yellow signal (no obvious regulation); and (3) red signal (up regulation).

Data analysis

The cy3 and cy5 signal intensities were quantified by Gene Pix Pro 3.0 software (Axon Instruments, Inc., Foster City, CA). Subsequently, we normalized the obtained numerical data with classical linear regression techniques. In brief, quantified cy3 and cy5 signal intensities were obtained when foreground signal intensities were deducted by background signal intensities and cy5 signal intensities were replaced by 200 when it was < 200. When Ri (Ri = cy5/cy3) was between 0.1 and 10, Ri was taken logarithms base natural to generate Ri’[log (Ri)] and ND was taken by EXP (R) (averaged Ri’). The modified cy3* was generated when ND was multiplied by cy3, and was replaced by 200 when it was < 200. The ratio was expressed as cy5/cy3*. Therefore, we selected genes whose ratio was more than 2 or less than 0.5 representing a 2-fold difference in expression level. To analyze the selected gene expression data, we applied κ-means cluster analysis, and performed GeneMaths hierarchical clustering to appraise the number of groups. Whole analyses were executed with Microsoft Excel (Microsoft, Redmond, WA) and GeneSpring (Silicon Genetics, San Carlos, CA).

Category and expression changes of genes related to rat liver regeneration

Among the tested 551 genes, 216 were identified to be altered by more than 2-fold in intensity at least at one time point in the 0-36-72-96-144 h SISPH. Of the 216 identified genes, 111 were up-regulated and 106 were down-regulated. Ninety-nine of these 216 genes were unreported genes and the other 117 were reported, of which quite a few genes had not been reported to be involved in LR. Based on the functions and the time points at which they showed maximum up- or down-regulation, those reported genes were respectively involved in stress response, glycometabolism, fat and stearoyl metabolism, oxidation and reduction response, regulation-proteins, glycoproteins, lipid-proteins, nucleolar proteins, receptors, factors, hemoglobins, immunological proteins, chaperonins, cytoskeletons, marker proteins, amino acid enzymes, proteolytic enzymes, proteinase inhibitors, phosphorylases, phosphatases, synthases and transferases (Table 1).

Table 1 The genes related to liver regeneration altered in 0-36-72-96-144h SISPH (*genes specially altered in SISPH ).
No. Gene descriptionFold differenceNo. Gene descriptionFold difference
Unreported genes*93 RP24-176A12.4
1 AW5581710.294 RP24-347B223
2 CG31759-PA295 RP32-28p170.4
*3 CH230-11N53.296 Adult male liver cDNA6.4
4 CH230-155H30.397 DNA segment of Chr 13.9
5 CH230-155H32.698 12 d embryo liver cDNA2.2
6 CH230-186B230.199 13 d embryo liver cDNA0.5
7 CH230-206C200.2Stress response
8 CH230-329A50.5100 Alpha-1 major acute phase protein prepeptide13.6
9 CH230-372C240.1101 Petaxin2.6
10 CH230-403C200.3102 Angiotensinogen (Agt)5.8
*11 CH230-404C202.4103 Kininogen8
12 CH230-4L114104 T-kininogen16.1
13 CH230-7A220.1Glycometabolism
14 Citb585c70.3105 Aldolase B0.4
*15 CTD-2328C192.5*106 C-reactive protein2.6
*16 FLJ203562.7107 Glycerol 3-phosphate dehydrogenase (Gpd3)0.5
17 KIAA12302.8108 Isocitrate dehydrogenase 1 (Idh1)0.4
18 LOC1193922.3*109 Maize aldolase0.5
*19 LOC3113042*110 3-phosphoglycerate dehydrogenase17.6
*20 LRRP Aa1-0182.8Fatty and stearoyl metabolism
21 LRRP Aa10274111 Malonyl-CoA decarboxylase0.4
*22 LRRP Aa1-0762.6112 NAD(P) dependent steroid hydrogenase0.5
*23 LRRP Aa1-1142.4113 P450 cholesterol 7- -hydroxylase (P450 VII)3
24 LRRP Aa2-0200.5114 Prostaglandin D2 synthase 2 (Ptgds2)2
25 LRRP Aa2-0660.4*115 Retinol dehydrogenase 110.5
*26 LRRP Aa2-1112.5116 3-alpha-hydroxysteroid dehydrogenase0.3
27 LRRP Aa2-1740.1Oxidation and reduction response
28 LRRP Aa2-2963.1117 Acyl-coA oxidase0.2
29 LRRP Ab1-0214.9118 Alcohol dehydrogenase (ADH)0.4
30 LRRP Ab1-0462.9119 Cytochrom P450 15-beta (Cyp2c12)0.1
31 LRRP Ab1-1083120 Cytochrome b0.5
32 LRRP Ab1-1143.4121 Cytochrome b5 (Cyb5)0.4
*33 LRRP Ab1-1192.1122 Cytochrome P4500.2
34 LRRP Ab1-1520.5123 Cytochrome P450 (PNCN inducible, Cyp3A1)0.4
35 LRRP Ab1-2164.7124 Cytochrome P450 2E10.1
36 LRRP Ab1-3313125 Cytochrome P450, 2c39 (Cyp2c39)0.4
37 LRRP Ab1-3343.6*126 CytochromeP450, 2b19 (Cyp2b15)0.4
38 LRRP Ab2-0010.5127 CytP450 arachidonic acid epoxygenase (cyp 2C23)0.2
39 LRRP Ab2-0010.5128 Flavin-containing monooxygenase 1 (Fmo1)0.1
40 LRRP Ab2-0082.1129 Paraoxonase 1 (Pon1)0.1
*41 LRRP Ab2-0182*130 Peroxiredoxin 1 (Prdx1)0.4
42 LRRP Ab2-0343*131 Plasma selenoprotein P1 (Sepp1)2.8
*43 LRRP Ab2-0570.4132 Selenium-dependent glutathione peroxidase0.2
*44 LRRP Ab2-0792Regulation-proteins
*45 LRRP Ab2-0932.1133 II-protein with tetratricopeptide repeats 32.3
46 LRRP Ab2-0954.6*134 Glu-Pro dipeptide repeat protein0.4
47 LRRP Ab2-1320.4135 RAKb0.5
48 LRRP Ab2-1432Glycoproteins
49 LRRP Ab2-2250.3136 Alpha-1-B glycoprotein (A1bg)0.1
*50 LRRP Ab2-2550.5137 Fibrinogen, gamma polypeptide (Fgg)7.2
51 LRRP Ab2-3793.1138 Fibronectin 1 (Fn1)5
*52 LRRP Ab2-3902.1139 Histidine-rich glycoprotein (Hrg)0.4
53 LRRP Ab2-4020.4140 Myelin-associated glycoprotein (L-MAG)0.3
54 LRRP Ac1-0602.7141 TRAM12.6
55 LRRP Ac1-1630.5142 UDP-glucuronosyltransferase 2B3 (Udpgt)0.3
56 LRRP Ac11770.4Lipid-proteins
57 LRRP Ac1-2333.3143 Apolipoprotein C-I (Apoc1)0.4
58 LRRP Ac18737.1144 Apolipoprotein C-II0.3
59 LRRP Ac2-0613.8145 Apolipoprotein C-III0.4
60 LRRP Ac2-1250.2146 C57BL/6J2.2
61 LRRP Ac2-1434147 Fatty acid binding protein 1 (Fabp1)0.2
62 LRRP Ac2-1933.1148 Plasma retinol-binding protein (PRBP)0.5
63 LRRP Ac2-2024.1149 Transthyretin-related protein (TTN)0.2
64 LRRP Ac2-2232.1Nucleolar proteins
*65 LRRP Ac2-2562.2150 RNase A family 40.4
*66 LRRP Ac2-2820.5Receptors
*67 LRRP Ac2-3000.4151 Cocoa protein5.5
68 LRRP Ba1-6473.9*152 Golgi SNAP receptor member 1 (Gosr1)0.4
69 LRRP Bm4032077.9153 Nuclear receptor subfamily 0, mem 2 (Nr0b2)0.2
70 LRRP Cc1-270.4154 Type I interleukin 1 receptor (Il1r1)6.2
71 LRRP Cc1-82.6Factors
72 LRRP Cc1-94.7155 Angiogenin0.3
*73 LRRP Da1-102.1156 Angiopoietin-like 30.5
74 LRRP Da1-242.8157 Early growth response factor 1 (Egr1)2.4
75 LRRP Da1-62.9158 Eukaryotic translation initiation factor 4A12.5
*76 LRRP Da2-192.6159 Insulin-like growth factor I0.5
*77 LRRP Da2-352.3160 Neuropeptide Y (Npy)3.9
*78 LRRP Da2-42.3Hemoglobins
79 LRRP zbs5590.4161 Hemoglobin, alpha 1 (Hba1)0.3
*80 MGC389372.6162 Hemoglobin beta chain (Hbb)0.3
81 RIKEN 1110061A243.5Immunological proteises
82 RIKEN 1300002A080.4163 Achaete-scute complex homolog-like 1 (Ascl1)0.3
*83 RIKEN 1500012D082.2164 Complement component 5 (C5)8.6
*84 RIKEN 2310045J230.5165 Immunoglobulin C kappa0.2
85 RIKEN 2810051A142*166 Fc-gamma receptor class III5.5
*86 RIKEN 4930408O210.5167 JE/MCP-16.1
87 RP11-281N100.5191 Alpha-1-macroglobulin3.1
88 RP23-195K13.9192 Contrapsin-like protease inhibitor (CPi-26)14.1
89 RP23-235O10.4193 Leuserpin-2 (Serpind1)0.5
90 RP23-35D40.5194 Serine protease inhibitor 14.6
91 RP23-417P220.4Phosphorylases
92 RP23-480P210.5*195 CDK1032.5
Chaperonins196 CDK1100.5
*168 DnaJ (Hsp40), subfamily B, mem 11 (Dnajb11)2.6197 Mss4 protein3.6
*169 TCP-1 containing cytosolic chaperonin (CCT)0.5*198 Rho-associated kinase beta (Rock1)0.5
Cytoskelets199 Thymidylate kinase (dTMP kinase)2.8
170 Actin gamma2.7Phosphatases
*171 Actin beta (Actb)3200 Pyrophosphatase/phosphodiesterase 1(Enpp1)4.2
172 Clathrin, heavy polypeptide (Hc) (Cltc)2.7201 Phosphatase 1 (GL-subunit)0.2
173 Karyopherin (importin) alpha 20.4202 Phosphatidylserine-specific phospholipase A13
*174 Mutant beta-actin (beta-actin)3.4*203 Secreted phosphoprotein 1 (Spp1)2.2
*175 Ribosomal protein S12 (Rps12)2.2*204 UTP-glucose-1-phosphate0.4
Marker proteinsSynthases
176 ATP-binding cassette, sub-family C0.3*205 ATPase synthase subunit 62.3
*177 CD164 antigen (Cd164)0.4206 Carbamyl phosphate synthetase I3.3
*178 CD44 antigen (Cd44)2.2*207 Glutamyl-prolyl-tRNA synthetase (Eprs)2.6
179 Pregnancy-zone protein (Pzp)4.7Transferases
180 Serum amyloid a-5 protein45.1208 Carnitine O-octanoyltransferase (Crot)0.3
181 Subchromosomal transferable fragment 40.5209 Glutathione S-transferase 1 (Mgst1)0.5
Amino acid enzymes*210 Glutathione S-transferase Y(b) subunit0.4
182 Cytosolic aspartate aminotransferase5.1211 Glutathione S-transferase, alpha 1 (Gsta1)0.1
*183 Phenylalanine hydroxylase (Pah)0.4212 Glutathione S-transferase, type 3 (Yb3) (Gstm3)0.4
*184 Tissue-type transglutaminase (Tgm2)2.8213 Serine hydroxymethyl transferase 12.1
185 2-hydroxyphytanoyl-CoA lyase (Hpcl2)0.4214 Sialyltransferase 1 (Siat1)4.4
Proteolytic enzymes215 Sulfotransferase K20.2
*186 Alpha/beta hydrolase domain containing protein 12.9216 UDP-glucuronosyltransferase 2, mem 5 (Ugt2b5)10.4
187 Cathepsin C (Ctsc)0.4
*188 Proteasome (macropain subunit, beta type 6 Psmb6)0.4
Proteinase inhibitors
189 Alpha-1 microglobulin/bikunin (Ambp)0.4
190 Alpha-2-macroglobulin (A2m)8.1
Gene expression differences at various time points of the 0-36-72-96-144 h SISPH

The gene expression profiles at different time points were generalized at 36, 36-72, 36-96, 36-144, 72, 72-96, 72-144, 96, 96-144, 144 h, and it was found that at 36 h of SISPH, 17 genes were up-regulated and 2 were down-regulated; at the time points of 36 h and 72 h of SISPH, 3 genes were up-regulated and 3 down-regulated; at the time points of 36 h and 96 h of SISPH, only 2 genes were up-regulated; at the time points of 36 h and 144 h of SISPH, 32 genes were up-regulated and 23 genes down-regulated, which is the largest group at all time points of SISPH; at 72 h of SISPH, 13 genes were down-regulated and 12 up-regulated. At the time points of 72 h and 96 h of SISPH, 5 genes were down-regulated and 4 up-regulated; at the time points of 72 h and 144 h of SISPH, 14 genes were up-regulated and 21 down-regulated; at 96 h of SISPH, one gene were up-regulated and 6 down-regulated; at the time points of 96 h and 144 h of SISPH, 10 genes were down-regulated and 7 up-regulated; at 144 h of SISPH, 11 genes were up-regulated and 31 down-regulated. Briefly, the LR of 0-36-72-96-144 h SISPH involved 216 elements, of which, 111 were up-regulated and 105 were down-regulated (Figure 1).

Figure 1
Figure 1 Gene expression differences in the regenerating rat liver of 0-36-72-96-144 h SISPH.
Gene expression level in the regenerating rat liver of 0-36-72-96-144 h SISPH

According to the up-regulated and down-regulated intensity of genes in the 0-36-72-96-144 h SISPH, we categorized the genes into 3 groups: (1) 105 genes were down-regulated by less than 50%; (2) 93 genes were up-regulated by 2-5 fold; (3) 18 genes were strongly up-regulated by more than 5-fold (Figure 2).

Figure 2
Figure 2 Expression level of genes in the regenerating rat liver of 0-36-72-96-144 h SISPH.
Hierarchical cluster analysis of genes expressed in the liver regeneration

The expression profile of the 216 genes altered by more than 2-fold in intensity at least at one time point in the 0-36-72-96-144 h SISPH was emanative to the last time point, indicating that at 144 h of SISPH, the liver regeneration has not been completed yet (Figure 3A). We undertook hierarchical clustering of 5 time points (0, 36, 72, 96 and 144 h) of SISPH using GeneSpring software and discovered that gene expression profiles had no similarity at the four time points (Figure 3B).

Figure 3
Figure 3 Cluster analysis of 216 elements. A: The difference of their intensity was identified more than two-fold at least at one time point. B: A hierarchical clustering of five time points indicated that the genes at these time points hardly had a common expression profile.

To facilitate the visualization and interpretation of the gene expression program presented in this very large body of data, we used the method of κ-means to order genes on the basis of similarities in their expression patterns and displayed the results in a compact graphical format, generating 8 kinds of ramose gene expression clusters (Figure 4). We then categorized the selected elements into 8 distinct temporal induction or suppression patterns immediate induction, middle induction, late induction, consistent induction, immediate suppression, middle suppression, late suppression, consistent suppression (Figure 5).

Figure 4
Figure 4 Cluster analysis of gene expression profiles identified by cDNA microarray. These genes were classified into 8 clusters by the κ-means method.
Figure 5
Figure 5 Category of the 216 elements. Based on the results of the cluster analysis, eight distinct temporal patterns were designated. A: Immediate induction, B: Middle induction, C: Late induction, D: Consistent induction, E: Immediate suppression, F: Middle suppression, G: Late suppression, H: Consistent suppression.
Comparison of gene expression in SISPH with that after PH

Comparison of gene expression profile in SISPH with that after PH revealed that 56 genes were specially induced by SISPH, and the expression of 160 genes was altered simultaneously with the same trend in both SISPH and PH, but the time points of their expression and degree of up-regulation and down-regulation were different (Table 2).

Table 2 The comparison of difference of gene expression in SISPH with that after in PH.
Gene descriptionFold difference
Gene descriptionFold difference
Unreported genesCytochrome P450 (PNCN inducible, Cyp3A1)0.40.2
AW5581710.20.3Cytochrome P450 2E10.10.1
CG31759-PA22.9Cytochrome P450, 2c39 (Cyp2c39)0.40.1
CH230-155H30.30.3CytP450 arachidonic acid epoxygenase (cyp 2C23)0.20.2
CH230-155H32.62.2Flavin-containing monooxygenase 1 (Fmo1)0.10.1
CH230-186B230.10.2Paraoxonase 1 (Pon1)0.10.2
CH230-206C200.20.3Selenium-dependent glutathione peroxidase0.20.4
CH230-372C240.10.1II-protein with tetratricopeptide repeats 32.30.2
CH230-7A220.10.1Alpha-1-B glycoprotein (A1bg)0.10.1
Citb585c70.30.2Fibrinogen, gamma polypeptide (Fgg)7.27.2
KIAA12302.82.6Fibronectin 1 (Fn1)57.2
LOC1193922.32.1Histidine-rich glycoprotein (Hrg)0.40.1
LRRP Aa102742.1Myelin-associated glycoprotein (L-MAG)0.37
LRRP Aa2-0200.50.4TRAM12.65.1
LRRP Aa2-0660.40.4UDP-glucuronosyltransferase 2B3 (Udpgt)0.30.3
LRRP Aa2-1740.10.1Lipid-proteins
LRRP Aa2-2963.12.1Apolipoprotein C-I (Apoc1)0.43.3
LRRP Ab1-0214.98.1Apolipoprotein C-II0.30.3
LRRP Ab1-0462.90.5Apolipoprotein C-III0.40.5
LRRP Ab1-10832.9C57BL/6J2.27.3
LRRP Ab1-1143.44.2Fatty acid binding protein 1 (Fabp1)0.20.3
LRRP Ab1-1520.50.4Plasma retinol-binding protein (PRBP)0.50.4
LRRP Ab1-2164.76.8Transthyretin-related protein (TTN)0.20.3
LRRP Ab1-33132.2Nucleolar proteins
LRRP Ab1-3343.62.7RNase A family 40.40.2
LRRP Ab2-0010.50.2Receptors
LRRP Ab2-0010.50.2Cocoa protein5.54.6
LRRP Ab2-0082.12.1Nuclear receptor subfamily 0, mem 2 (Nr0b2)0.20.2
LRRP Ab2-03432.3Type I interleukin 1 receptor (Il1r1)6.27.8
LRRP Ab2-0954.63.1Factors
LRRP Ab2-1320.40.1Angiogenin0.30.2
LRRP Ab2-14323.3Angiopoietin-like 30.50.2
LRRP Ab2-2250.30.3Early growth response factor 1 (Egr1)2.43.6
LRRP Ab2-3793.12.2Eukaryotic translation initiation factor 4A12.53.8
LRRP Ab2-4020.40.1Insulin-like growth factor I0.50.5
LRRP Ac1-0602.70.4,2.3Neuropeptide Y (Npy)3.918.2
LRRP Ac1-1630.50.4Hemoglobins
LRRP Ac11770.40.4, 3.3Hemoglobin, alpha 1 (Hba1)0.30.3
LRRP Ac1-2333.34.2Hemoglobin beta chain (Hbb)0.30.3
LRRP Ac18737.16Immunological proteises
LRRP Ac2-0613.87.6Achaete-scute complex homolog-like 1 (Ascl1)0.30.4
LRRP Ac2-1250.20.3Complement component 5 (C5)8.68.8
LRRP Ac2-14343.3Immunoglobulin C kappa0.20.2
LRRP Ac2-1933.12.3JE/MCP-16.14
LRRP Ac2-2024.12.5Cytoskelets
LRRP Ac2-2232.12.4Actin gamma2.74.7
LRRP Ba1-6473.93.2Clathrin, heavy polypeptide (Hc) (Cltc)2.73.3
LRRP Bm4032077.95.7Karyopherin (importin) alpha 20.40.4
LRRP Cc1-270.42.2Marker proteins
LRRP Cc1-82.62.3ATP-binding cassette, sub-family C0.30.4
LRRP Cc1-94.72.5Pregnancy-zone protein (Pzp)4.72.4
LRRP Da1-242.83.5Serum amyloid a-5 protein45.190.5
LRRP Da1-62.92Subchromosomal transferable fragment 40.50.3
LRRP zbs5590.43.1Amino acid enzymes
RIKEN 1110061A243.53Cytosolic aspartate aminotransferase5.15.3
RIKEN 1300002A080.40.3, 2.42-hydroxyphytanoyl-CoA lyase (Hpcl2)0.40.4
RIKEN 2810051A1422.7Proteolytic enzyme
RP11-281N100.50.3Cathepsin C (Ctsc)0.40.4
RP23-195K13.92.4Proteinase inhibitor
RP23-235O10.40.2Alpha-1 microglobulin/bikunin (Ambp)0.42.1
RP23-35D40.50.4, 2.8Alpha-2-macroglobulin (A2m)8.121.3
RP23-480P210.50.4Contrapsin-like protease inhibitor (CPi-26)14.16.6
RP24-347B2232.2Leuserpin-2 (Serpind1)0.50.2
RP32-28p170.40.3Serine protease inhibitor 14.65
Adult male liver cDNA6.40.1Phosphorylases
DNA segment of Chr 13.96.1CDK1100.50.5
13 d embryo liver cDNA0.55.9Mss4 protein3.62.1
Stress responseThymidylate kinase (dTMP kinase)2.83
Alpha-1 major acute phase protein prepeptide13.66.2Phosphatases
Petaxin2.62.2Pyrophosphatase/phosphodiesterase 1(Enpp1)4.26.6
Angiotensinogen (Agt)5.88.4Phosphatase 1 (GL-subunit)0.20.2
Kininogen83.4Phosphatidylserine-specific phospholipase A132.8
GlycometabolismCarbamyl phosphate synthetase I3.32.9
Aldolase B0.40.3Transferases
Glycerol 3-phosphate dehydrogenase (Gpd3)0.50.4Carnitine O-octanoyltransferase (Crot)0.30.3
Isocitrate dehydrogenase 1 (Idh1)0.40.3Glutathione S-transferase 1 (Mgst1)0.50.4
Fatty and stearoyl metabolismGlutathione S-transferase Y(b) subunit0.40.3
Malonyl-CoA decarboxylase0.40.3Glutathione S-transferase, alpha 1 (Gsta1)0.10.1
NAD(P) dependent steroid hydrogenase0.50.4Glutathione S-transferase, type 3 (Yb3) (Gstm3)0.40.3
P450 cholesterol 7- -hydroxylase (P450 VII)30.5, 2.3Sialyltransferase 1 (Siat1)4.42.6
Prostaglandin D2 synthase 2 (Ptgds2)23Sulfotransferase K20.20.3
3-alpha-hydroxysteroid dehydrogenase0.30.2UDP-glucuronosyltransferase 2, mem 5 (Ugt2b5)00.3
Oxidation and reduction response
Acyl-coA oxidase0.20.4, 2.7
Alcohol dehydrogenase (ADH)0.40.1, 2.4
Cytochrom P450 15-beta (Cyp2c12)0.10.2
Cytochrome b0.50.5
Cytochrome b5 (Cyb5)0.40.2
Cytochrome P4500.20.2

This study found that 111 genes were up-regulated in the 0-36-72-96-144 h SISPH, suggesting that they could promote the liver growth, development and regeneration. It was also found that a large number of genes were related to positive and negative acute phase reaction to the successive hepatectomy, which suggests that these genes might regulate the balance of cell proliferation and death in the acute-phase response.

In the 25 genes up-regulated to reach the highest level at 36 h of 0-36-72-96-144 h SISPH, 20 genes were decreased immediately to control level after the peak of 36 h, but 5 kept a high level until 144 h of SISPH. Among them, 3-phosphoglycerate dehydrogenase (PGDH) was reported to catalyze the first step in serine biosynthesis and was increased in regenerating liver[21-23]. Prostaglandin D2 synthase 2 was confirmed to play an important role in reproduction as a PGD2-producing enzyme and a retinoid transporter[24,25]. Phosphoprotein 1 was involved in regulation of hepatocyte proliferation in LR[26]. The maximum expression of these genes at 36 h of SISPH showed that they could regulate hepatocyte multiplication after the peak of DNA replication in LR.

In the 27 genes up-regulated to reach the highest level at 72 h of 0-36-72-96-144 h SISPH, 12 of them declined gradually to control level at 96-144 h, and 6 did not decline until 144 h of SISPH, of which eIF4A1 was reported to control melanoma cell proliferation by over expression[27], whose up-regulation was assumed to accelerate protein synthesis at 72 h of SISPH. Actin γ played specific roles in the growth of liver parenchymal cells in the LR of SISPH[28]. Cocoa extract could protect against early alcohol-induced liver injury in the rat[29], whose conduction at 72 h was presumed to be involved in relieving hepatocytes from alcohol damage in LR of SISPH. Alpha-2-macroglobulin (A2M) was confirmed to reduce paracrine-and autocrine-stimulated extracellular matrix synthesis by scavenging TGF-beta[30]. The successive induction of alpha 2-macroglobulin, a multifunctional binding protein with protease and cytokine scavenging properties[31], may restrain protein degradation and termination of TGF-β in LR. The increase of HSP40 at 72 h means that lots of newly synthesized proteins need to correctly fold with help of HSP40 in LR of SISPH.

In the 11 genes up-regulated to reach the highest level at 96 h of 0-36-72-96-144 h SISPH, cytochrome P450 cholesterol 7-alpha-hydroxylase (CYP7) is confirmed to regulate the protein modeling and the mRNA level in response to multiple physiological activities, including liver cholesterol synthesis, bile acid feedback inhibition, and diurnal rhythm[32,33]. The conduction of CYP7 at 96 h is supposed to relate with cholesterol synthesis and hormone regulation in LR of SISPH.

In the 48 genes up-regulated to reach the highest level at 144 h of 0-36-72-96-144 h SISPH, plasma fibronectin was decreased in favor of LR impairment[34-36], its expression at 144 h indicated that fibronectin-mediated function between the cells and the extracellular matrix was active in LR of SISPH. α-1-macroglobulin, serine protease inhibitor 1, angiotensinogen (Agt), fibrinogen γ, pregnancy-zone protein (Pzp) were always up-regulated from 36 h to 144 h of 0-36-72-96-144 h SISPH, suggesting that they are necessary for inhibiting proteolysis and facilitating cell growth and connection at these time points of SISPH. α-1 major acute phase protein (alpha 1-MAP) is one of the cysteine protease inhibitors[37]. Complement component 5 can increase hepatic glycogenolysis by a prostanoid-mediated intercellular communication between Kupffer cells and hepatocytes[38]. Fc-γ receptor III is responsible for IgG-dependent cell cytotoxicity and production of several cytokines and chemokines and involved in macrophage inflammatory protein 1α (MIP-1alpha) and neutrophil influx[39-41]. JE/MCP-1 is known as a CC chemokine attracting monocytes, basophils and T-lymphocytes[42,43]. Serum amyloid A-5 (SAA-5) is a major acute-phase protein synthesized and secreted mainly by the liver[44], and is increased in response to acute inflammation in LR of SISPH. T-kininogen and kininogen are promoters to IL-6 as LR signal. These genes were always up regulated from 36 h to 144 h of 0-36-72-96-144 h SISPH, suggesting that they are necessary for relinquishing inflammation and promoting growth in whole SISPH.

This study found that 105 genes were suppressed in 0-36-72-96-144 h SISPH and a large number of them were related to energy metabolism, suggesting that they restrain LR by various paths, and that the need for energy in LR of SISPH is not as important as for other demand, which is different after PH.

Eight genes were suddenly down-regulated at 36 h after SISPH, including histidine-rich glycoprotein (HRG), apolipoprotein C-I (Apo C-I), retinol-binding protein (PRB), cytochrome P450 3A1 (Cyp3A1), RNase A family 4, carnitine O-octanoyltransferase (Crot), cytochrome b5 (Cyb5), etc. Histidine-rich glycoprotein (HRG) is confirmed an abundant serum exhibitive protein in diverse biological systems, whose combination with zinc could be used as an antidote for heparin[45,46]. Therefore, the down-regulation of HRG at 36 h indicated that the increased activity of heparin is essential for LR of SISPH. Apo C-I is known associated with the lipid surface of the plasma chylomicron, VLDL, and HDL subfractions, and reverse transfer from VLDL to HDL and to SBV[47], acting as a major plasma inhibitor of cholesteryl ester transfer protein and phospholipase inhibitor[48,49]. From the above evidence, a low level of Apo C-I at 36 h is supposed to facilitate lipoprotein linkage to LDL receptor, LDL receptor-related protein, and VLDL receptor, as well as fatty acid uptake of hepatocytes in LR of SISPH. Cyp3A1 enzymes belong to the most abundant subfamily of the cytochrome P-450 system that is predominantly found in the liver where they metabolize numerous drugs and endogenous substances such as oestrogens[50]. The down-regulation of cyp 3A1 suggested that the harm induced by hepatectomy was presumably distinct from that by drugs and endogenous substances in rat liver.

Twenty-nine genes were suppressed and had a minimum expression at 72 h in after SISPH. Among them, angiopoietin-like protein 3 (Angptl3) is reported to activate lipolysis in adipocytes as a vascular endothelial growth factor by response to the liver X receptor (LXR)[51]. The extensive suppression of angiopoietin-like protein 3 mRNA at 72 h suggested that the activity of lipolysis of hepatocytes was very low in LR of SISPH. Acyl-CoA can play many important roles in numerous biochemical reactions, such as tricarboxylic acid cycle, glycoxylate bypass, fatty acid synthesis. The mRNA level of acyl-coA oxidase was first dropped to meet the condition and later increased to eliminate over expressed acyl-CoA in LR of SISPH.

Hpcl 2 was expressed at 96 h in SISPH, and involved in the carbon-carbon bond cleavage as peroxisomal pyrophosphate-dependent enzyme during α-oxidation of 3-methyl-branched fatty acids[52,53]. Down-regulation of Hpcl 2 can protect phytanic acid against being broken down, which may store energy during LR of SISPH. Fmo1 can lead to the decrease of cytochrome P-450[54], which was repressed at 96 h to accommodate electronic environment for hepatocyte multiplication in LR of SISPH.

Retinoic acid is known necessary for the maintenance of many lining epithelia of the body, whereas retinol dehydrogenase can catalyze the first step in retinoic acid biosynthesis[55]. Its suppression at 144 h after SISPH demonstrates that retinoic acid is not necessary in late phase of LR. In normal liver the activity of ADH is in excess, while in regenerating rat liver, the rate of ethanol elimination may be limited by the activity of alcohol dehydrogenase in SISPH[56]. Cathepsin C (Ctsc) and dipeptidyl aminopeptidase I are regarded to play an important role in protein degradation and the activation of proenzyme in rat liver[57]. The down-regulation of cathepsin C may be due to the indispensability of peptide for protein construction in LR of SISPH. Hepatectomy is reported to decrease liver cytochrome P450 levels by inducing heme oxygenase and inhibiting ALA synthase activities[58], which was inhibited at 144 h to regulate the oxidation reaction of hepatocytes in LR of SISPH. Glutathione S-transferase (GST) is a family of conjugative enzymes that catalyze neucleophilic addition of tripeptide glutathione to xenobiotics carcinogens and endogenous lipophilic compounds[59]. It was manifested that xenobiotics carcinogens and endogenous lipophilic might produce some uncertain toxic effect on LR of SISPH. Glutathione S-transferase type 3 (Yb3) mRNA was always hampered, implying that over accumulation of Yb3 could lead to contrary reaction. Fatty binding protein is well known to transfer fat from cytoplasm to nuclear or membrane, and fatty acid elongase 1 (rELO1) catalyzes short chain fat transition to long chain fat. The repression of its mRNA in SISPH indicates that long chain fatty acid was not in badly need until 144 h in LR of SISPH. Leuserpin-2 (Sperpind1) was confirmed to participate in complement activation in fibrinolysis and inflammatory response[60], which was continuously repressed in SISPH, suggesting that it can regulate inflammatory response to improve severely injured hepatocytes in LR of SISPH. Myelin-associated glycoprotein (MAG)-binding activity of novel sulfated GM1b, high-affinity ligands for neural singles is important to nervous system regeneration[61]. The repression of MAG at 144 h of SISPH may result in mild damage of hepatocytes and nerve system in late phase of LR.

In conclusion, further experiments will be done by using sham surgical rats as control, so as to confirm which genes reported in this paper are related to surgical operation, and which are really related to liver regeneration.


The authors gratefully acknowledge BioStar for microarray.


Edited by Zhu LH Proofread by Chen WW and Xu FM

1.  Michalopoulos GK, DeFrances MC. Liver regeneration. Science. 1997;276:60-66.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 2376]  [Cited by in F6Publishing: 2223]  [Article Influence: 95.0]  [Reference Citation Analysis (0)]
2.  Taub R. Liver regeneration 4: transcriptional control of liver regeneration. FASEB J. 1996;10:413-427.  [PubMed]  [DOI]  [Cited in This Article: ]
3.  Fausto N. Liver regeneration. J Hepatol. 2000;32:19-31.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 838]  [Cited by in F6Publishing: 282]  [Article Influence: 38.1]  [Reference Citation Analysis (0)]
4.  Zimmermann A. Liver regeneration: the emergence of new pathways. Med Sci Monit. 2002;8:RA53-RA63.  [PubMed]  [DOI]  [Cited in This Article: ]
5.  Nagy P, Bisgaard HC, Schnur J, Thorgeirsson SS. Studies on hepatic gene expression in different liver regenerative models. Biochem Biophys Res Commun. 2000;272:591-595.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 6]  [Cited by in F6Publishing: 6]  [Article Influence: 0.3]  [Reference Citation Analysis (0)]
6.  Gressner AM. Cytokines and cellular crosstalk involved in the activation of fat-storing cells. J Hepatol. 1995;22:28-36.  [PubMed]  [DOI]  [Cited in This Article: ]
7.  Cressman DE, Diamond RH, Taub R. Rapid activation of the Stat3 transcription complex in liver regeneration. Hepatology. 1995;21:1443-1449.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 231]  [Cited by in F6Publishing: 150]  [Article Influence: 8.6]  [Reference Citation Analysis (0)]
8.  FitzGerald MJ, Webber EM, Donovan JR, Fausto N. Rapid DNA binding by nuclear factor kappa B in hepatocytes at the start of liver regeneration. Cell Growth Differ. 1995;6:417-427.  [PubMed]  [DOI]  [Cited in This Article: ]
9.  Fukuhara Y, Hirasawa A, Li XK, Kawasaki M, Fujino M, Funeshima N, Katsuma S, Shiojima S, Yamada M, Okuyama T. Gene expression profile in the regenerating rat liver after partial hepatectomy. J Hepatol. 2003;38:784-792.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 69]  [Cited by in F6Publishing: 29]  [Article Influence: 3.8]  [Reference Citation Analysis (0)]
10.  Sato Y, Igarashi Y, Hakamata Y, Murakami T, Kaneko T, Takahashi M, Seo N, Kobayashi E. Establishment of Alb-DsRed2 transgenic rat for liver regeneration research. Biochem Biophys Res Commun. 2003;311:478-481.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 33]  [Cited by in F6Publishing: 30]  [Article Influence: 1.8]  [Reference Citation Analysis (0)]
11.  Qin JM, Fu XY, Li SJ, Liu SQ, Zeng JZ, Qiu XH, Wu MC, Wang HY. Gene and protein expressions of p28GANK in rat with liver regeneration. World J Gastroenterol. 2003;9:2523-2527.  [PubMed]  [DOI]  [Cited in This Article: ]
12.  Mars WM, Kim TH, Stolz DB, Liu ML, Michalopoulos GK. Presence of urokinase in serum-free primary rat hepatocyte cultures and its role in activating hepatocyte growth factor. Cancer Res. 1996;56:2837-2843.  [PubMed]  [DOI]  [Cited in This Article: ]
13.  Jensen SA. Liver gene regulation in rats following both 70 or 90% hepatectomy and endotoxin treatment. J Gastroenterol Hepatol. 2001;16:525-530.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 10]  [Cited by in F6Publishing: 11]  [Article Influence: 0.5]  [Reference Citation Analysis (0)]
14.  Enami Y, Kato H, Murakami M, Fujioka T, Aoki T, Niiya T, Murai N, Ohtsuka K, Kusano M. Anti-transforming growth factor-beta1 antibody transiently enhances DNA synthesis during liver regeneration after partial hepatectomy in rats. J Hepatobiliary Pancreat Surg. 2001;8:250-258.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 14]  [Cited by in F6Publishing: 16]  [Article Influence: 0.7]  [Reference Citation Analysis (0)]
15.  Xia M, Xue SB, Xu CS. Shedding of TNFR1 in regenerative liver can be induced with TNF alpha and PMA. World J Gastroenterol. 2002;8:1129-1133.  [PubMed]  [DOI]  [Cited in This Article: ]
16.  Tang W, Liang K, Wang J, Du L, Zhang W. Effects of pHGF on hepatocyte DNA synthesis after partial hepatectomy in rats. J Tongji Med Univ. 1998;18:25-27.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 4]  [Cited by in F6Publishing: 2]  [Article Influence: 0.2]  [Reference Citation Analysis (0)]
17.  Xu CS, Lu AL, Xia M, Li XY, Li YH, Zhao XY. [The effect of heat shock before rat partial hepatectomy on HSC70/HSP68 expression and phosphatase activities]. Shiyan Shengwu Xuebao. 2000;33:1-11.  [PubMed]  [DOI]  [Cited in This Article: ]
18.  Li YC, Lin JT, Li WQ, Zhang HY, Wei MX, Xu CS. Cloning and functional analysis of up-regulated expressed genes in rat liver regeneration following short interval successive partial hepatectomy. Dev Rep Biol. 2002;11:151-160.  [PubMed]  [DOI]  [Cited in This Article: ]
19.  Li YC, Ma ZQ, Xu CS. Change of TNF-α, c-myc, p53, p21, PCNA, Bcl-2, TGF-β related with the cell prolification in rat liver regeneration following short interval successive partial hepatectomy. Dev Rep Biol. 2002;11:253-260.  [PubMed]  [DOI]  [Cited in This Article: ]
20.  Xu CS, Li YH, Duan RF, Lu AL, Xia M, Gu AL. Effects of the short interval successive partial hepatectomy on rat survival and liver tissue structure. Dongwu Xuebao. 2001;47:659-665.  [PubMed]  [DOI]  [Cited in This Article: ]
21.  Bell JK, Pease PJ, Bell JE, Grant GA, Banaszak LJ. De-regulation of D-3-phosphoglycerate dehydrogenase by domain removal. Eur J Biochem. 2002;269:4176-4184.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 14]  [Cited by in F6Publishing: 10]  [Article Influence: 0.7]  [Reference Citation Analysis (0)]
22.  Yamasaki M, Yamada K, Furuya S, Mitoma J, Hirabayashi Y, Watanabe M. 3-Phosphoglycerate dehydrogenase, a key enzyme for l-serine biosynthesis, is preferentially expressed in the radial glia/astrocyte lineage and olfactory ensheathing glia in the mouse brain. J Neurosci. 2001;21:7691-7704.  [PubMed]  [DOI]  [Cited in This Article: ]
23.  Snell K, Weber G. Enzymic imbalance in serine metabolism in rat hepatomas. Biochem J. 1986;233:617-620.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 48]  [Cited by in F6Publishing: 56]  [Article Influence: 1.3]  [Reference Citation Analysis (0)]
24.  Samy ET, Li JC, Grima J, Lee WM, Silvestrini B, Cheng CY. Sertoli cell prostaglandin D2 synthetase is a multifunctional molecule: its expression and regulation. Endocrinology. 2000;141:710-721.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 13]  [Cited by in F6Publishing: 11]  [Article Influence: 0.6]  [Reference Citation Analysis (0)]
25.  Saito S, Tsuda H, Michimata T. Prostaglandin D2 and reproduction. Am J Reprod Immunol. 2002;47:295-302.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 56]  [Cited by in F6Publishing: 55]  [Article Influence: 2.8]  [Reference Citation Analysis (0)]
26.  Kikuchi K, Kitamura K, Kakinoki Y, Nakamura K, Matsuzawa S, Saadat M, Mizuno Y. Gene expressions and activities of protein phosphatases 1 alpha, 2A and 2C in hepatocarcinogenesis and regeneration after partial hepatectomy. Cancer Detect Prev. 1997;21:36-43.  [PubMed]  [DOI]  [Cited in This Article: ]
27.  Eberle J, Fecker LF, Bittner JU, Orfanos CE, Geilen CC. Decreased proliferation of human melanoma cell lines caused by antisense RNA against translation factor eIF-4A1. Br J Cancer. 2002;86:1957-1962.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 31]  [Cited by in F6Publishing: 31]  [Article Influence: 1.6]  [Reference Citation Analysis (0)]
28.  Tanahashi T, Suzuki M, Itoh N, Mitsui Y. Enhancement of gamma-actin protein during liver regeneration: its accumulation in a region adjacent to the hepatocyte plasma membrane. J Biochem. 1995;118:355-363.  [PubMed]  [DOI]  [Cited in This Article: ]
29.  McKim SE, Konno A, Gäbele E, Uesugi T, Froh M, Sies H, Thurman RG, Arteel GE. Cocoa extract protects against early alcohol-induced liver injury in the rat. Arch Biochem Biophys. 2002;406:40-46.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 54]  [Cited by in F6Publishing: 17]  [Article Influence: 2.7]  [Reference Citation Analysis (0)]
30.  Smorenburg SM, Griffini P, Tiggelman AB, Moorman AF, Boers W, Van Noorden JF. alpha2-Macroglobulin is mainly produced by cancer cells and not by hepatocytes in rats with colon carcinoma metastases in liver. Hepatology. 1996;23:560-570.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 12]  [Cited by in F6Publishing: 7]  [Article Influence: 0.5]  [Reference Citation Analysis (0)]
31.  Schüftan GG, Bachem MG. Alpha2-macroglobulin reduces paracrine- and autocrine-stimulated matrix synthesis of cultured rat hepatic stellate cells. Eur J Clin Invest. 1999;29:519-528.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 10]  [Cited by in F6Publishing: 10]  [Article Influence: 0.4]  [Reference Citation Analysis (0)]
32.  Lee YH, Alberta JA, Gonzalez FJ, Waxman DJ. Multiple, functional DBP sites on the promoter of the cholesterol 7 alpha-hydroxylase P450 gene, CYP7. Proposed role in diurnal regulation of liver gene expression. J Biol Chem. 1994;269:14681-14689.  [PubMed]  [DOI]  [Cited in This Article: ]
33.  Massimi M, Lear SR, Huling SL, Jones AL, Erickson SK. Cholesterol 7alpha-hydroxylase (CYP7A): patterns of messenger RNA expression during rat liver development. Hepatology. 1998;28:1064-1072.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 35]  [Cited by in F6Publishing: 36]  [Article Influence: 1.5]  [Reference Citation Analysis (0)]
34.  Kwon AH, Inada Y, Uetsuji S, Yamamura M, Hioki K, Yamamoto M. Response of fibronectin to liver regeneration after hepatectomy. Hepatology. 1990;11:593-598.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 18]  [Cited by in F6Publishing: 14]  [Article Influence: 0.6]  [Reference Citation Analysis (0)]
35.  Chijiiwa K, Nakano K, Kameoka N, Nagai E, Tanaka M. Proliferating cell nuclear antigen, plasma fibronectin, and liver regeneration rate after seventy percent hepatectomy in normal and cirrhotic rats. Surgery. 1994;116:544-549.  [PubMed]  [DOI]  [Cited in This Article: ]
36.  Milliano MT, Luxon BA. Initial signaling of the fibronectin receptor (alpha5beta1 integrin) in hepatic stellate cells is independent of tyrosine phosphorylation. J Hepatol. 2003;39:32-37.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 28]  [Cited by in F6Publishing: 12]  [Article Influence: 1.6]  [Reference Citation Analysis (0)]
37.  Anderson KP, Heath EC. The relationship between rat major acute phase protein and the kininogens. J Biol Chem. 1985;260:12065-12071.  [PubMed]  [DOI]  [Cited in This Article: ]
38.  Hespeling U, Püschel GP, Jungermann K, Götze O, Zwirner J. Stimulation of glycogen phosphorylase in rat hepatocytes via prostanoid release from Kupffer cells by recombinant rat anaphylatoxin C5a but not by native human C5a in hepatocyte/Kupffer cell co-cultures. FEBS Lett. 1995;372:108-112.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 24]  [Cited by in F6Publishing: 1]  [Article Influence: 0.9]  [Reference Citation Analysis (0)]
39.  Arase N, Arase H, Hirano S, Yokosuka T, Sakurai D, Saito T. IgE-mediated activation of NK cells through Fc gamma RIII. J Immunol. 2003;170:3054-3058.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 30]  [Cited by in F6Publishing: 24]  [Article Influence: 1.6]  [Reference Citation Analysis (0)]
40.  Taube C, Dakhama A, Rha YH, Takeda K, Joetham A, Park JW, Balhorn A, Takai T, Poch KR, Nick JA. Transient neutrophil infiltration after allergen challenge is dependent on specific antibodies and Fc gamma III receptors. J Immunol. 2003;170:4301-4309.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 37]  [Cited by in F6Publishing: 35]  [Article Influence: 1.9]  [Reference Citation Analysis (0)]
41.  Song X, Shapiro S, Goldman DL, Casadevall A, Scharff M, Lee SC. Fcgamma receptor I- and III-mediated macrophage inflammatory protein 1alpha induction in primary human and murine microglia. Infect Immun. 2002;70:5177-5184.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 41]  [Cited by in F6Publishing: 16]  [Article Influence: 2.1]  [Reference Citation Analysis (0)]
42.  Kawahara RS, Deng ZW, Denkinger DJ, Deuel TF. Role of serine/threonine protein kinases in the induction of JE, a platelet-derived growth factor inducible gene. Biochem Biophys Res Commun. 1994;203:1815-1820.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 3]  [Cited by in F6Publishing: 3]  [Article Influence: 0.1]  [Reference Citation Analysis (0)]
43.  DiPietro LA, Polverini PJ, Rahbe SM, Kovacs EJ. Modulation of JE/MCP-1 expression in dermal wound repair. Am J Pathol. 1995;146:868-875.  [PubMed]  [DOI]  [Cited in This Article: ]
44.  Bing Z, Reddy SA, Ren Y, Qin J, Liao WS. Purification and characterization of the serum amyloid A3 enhancer factor. J Biol Chem. 1999;274:24649-24656.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 28]  [Cited by in F6Publishing: 34]  [Article Influence: 1.2]  [Reference Citation Analysis (0)]
45.  Gorgani NN, Smith BA, Kono DH, Theofilopoulos AN. Histidine-rich glycoprotein binds to DNA and Fc gamma RI and potentiates the ingestion of apoptotic cells by macrophages. J Immunol. 2002;169:4745-4751.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 40]  [Cited by in F6Publishing: 32]  [Article Influence: 2.0]  [Reference Citation Analysis (0)]
46.  Fu CL, Horn MK. Histidine-rich glycoprotein plus zinc to neutralize heparin. J Lab Clin Med. 2002;139:211-217.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 10]  [Cited by in F6Publishing: 11]  [Article Influence: 0.5]  [Reference Citation Analysis (0)]
47.  McKeone BJ, Massey JB, Knapp RD, Pownall HJ. Apolipoproteins C-I, C-II, and C-III: kinetics of association with model membranes and intermembrane transfer. Biochemistry. 1988;27:4500-4505.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 23]  [Cited by in F6Publishing: 23]  [Article Influence: 0.7]  [Reference Citation Analysis (0)]
48.  Shachter NS. Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism. Curr Opin Lipidol. 2001;12:297-304.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 219]  [Cited by in F6Publishing: 193]  [Article Influence: 10.4]  [Reference Citation Analysis (0)]
49.  Poensgen J. Apolipoprotein C-1 inhibits the hydrolysis by phospholipase A2 of phospholipids in liposomes and cell membranes. Biochim Biophys Acta. 1990;1042:188-192.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 26]  [Cited by in F6Publishing: 8]  [Article Influence: 0.8]  [Reference Citation Analysis (0)]
50.  Galant C, Gala JL, Van Den Berge V, Berlière M, Haumont E, Horsmans Y. Immunolocalisation of cytochrome P-450 3A enzymes in human breast carcinoma: relationship with tumour differentiation and steroid receptors. Pharmacol Toxicol. 2001;88:142-146.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 2]  [Cited by in F6Publishing: 2]  [Article Influence: 0.1]  [Reference Citation Analysis (0)]
51.  Shimamura M, Matsuda M, Kobayashi S, Ando Y, Ono M, Koishi R, Furukawa H, Makishima M, Shimomura I. Angiopoietin-like protein 3, a hepatic secretory factor, activates lipolysis in adipocytes. Biochem Biophys Res Commun. 2003;301:604-609.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 76]  [Cited by in F6Publishing: 26]  [Article Influence: 4.0]  [Reference Citation Analysis (0)]
52.  Foulon V, Antonenkov VD, Croes K, Waelkens E, Mannaerts GP, Van Veldhoven PP, Casteels M. Purification, molecular cloning, and expression of 2-hydroxyphytanoyl-CoA lyase, a peroxisomal thiamine pyrophosphate-dependent enzyme that catalyzes the carbon-carbon bond cleavage during alpha-oxidation of 3-methyl-branched fatty acids. Proc Natl Acad Sci USA. 1999;96:10039-10044.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 72]  [Cited by in F6Publishing: 63]  [Article Influence: 3.1]  [Reference Citation Analysis (0)]
53.  Jansen GA, Verhoeven NM, Denis S, Romeijn G, Jakobs C, ten Brink HJ, Wanders RJ. Phytanic acid alpha-oxidation: identification of 2-hydroxyphytanoyl-CoA lyase in rat liver and its localisation in peroxisomes. Biochim Biophys Acta. 1999;1440:176-182.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 17]  [Cited by in F6Publishing: 4]  [Article Influence: 0.7]  [Reference Citation Analysis (0)]
54.  Kedderis GL, Rickert DE. Loss of rat liver microsomal cytochrome P-450 during methimazole metabolism. Role of flavin-containing monooxygenase. Drug Metab Dispos. 1985;13:58-61.  [PubMed]  [DOI]  [Cited in This Article: ]
55.  Rexer BN, Ong DE. A novel short-chain alcohol dehydrogenase from rats with retinol dehydrogenase activity, cyclically expressed in uterine epithelium. Biol Reprod. 2002;67:1555-1564.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 28]  [Cited by in F6Publishing: 29]  [Article Influence: 1.5]  [Reference Citation Analysis (0)]
56.  Pösö AR, Pösö H. Ethanol elimination in regenerating rat liver: the roles of alcohol dehydrogenase and acetaldehyde. Acta Chem Scand B. 1979;33:249-255.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 10]  [Cited by in F6Publishing: 9]  [Article Influence: 0.2]  [Reference Citation Analysis (0)]
57.  Cigic B, Pain RH. Location of the binding site for chloride ion activation of cathepsin C. Eur J Biochem. 1999;264:944-951.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 46]  [Cited by in F6Publishing: 41]  [Article Influence: 2.0]  [Reference Citation Analysis (0)]
58.  Solangi K, Sacerdoti D, Goodman AI, Schwartzman ML, Abraham NG, Levere RD. Differential effects of partial hepatectomy on hepatic and renal heme and cytochrome P450 metabolism. Am J Med Sci. 1988;296:387-391.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 19]  [Cited by in F6Publishing: 19]  [Article Influence: 0.6]  [Reference Citation Analysis (0)]
59.  Atkins WM, Wang RW, Bird AW, Newton DJ, Lu AY. The catalytic mechanism of glutathione S-transferase (GST). Spectroscopic determination of the pKa of Tyr-9 in rat alpha 1-1 GST. J Biol Chem. 1993;268:19188-19191.  [PubMed]  [DOI]  [Cited in This Article: ]
60.  Ragg H, Ulshöfer T, Gerewitz J. On the activation of human leuserpin-2, a thrombin inhibitor, by glycosaminoglycans. J Biol Chem. 1990;265:5211-5218.  [PubMed]  [DOI]  [Cited in This Article: ]
61.  Ito H, Ishida H, Collins BE, Fromholt SE, Schnaar RL, Kiso M. Systematic synthesis and MAG-binding activity of novel sulfated GM1b analogues as mimics of Chol-1 (alpha-series) gangliosides: highly active ligands for neural siglecs. Carbohydr Res. 2003;338:1621-1639.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 21]  [Cited by in F6Publishing: 8]  [Article Influence: 1.2]  [Reference Citation Analysis (0)]